A Swiss-based company, OphthalmoPharma (OPPH) is focused on the development of innovative drugs and medical devices for ophthalmology. Pursuing a virtual pharmaceutical business model, OPPH has established strong partnerships with research facilities, scientists, physicians, and manufacturing and sales organizations.
Strategy OphthalmoPharma has a strong ability to source, in-license and develop compounds in several fields of ophthalmology. The Company develops selected products on his own and in partnership with renowned companies as well as out-licenses technologies based on outstanding science, addressing unmet medical needs and creating new standards of patient care.
beecomb powered by beecom - beecomb the Professional Swiss CMS
